Results
Cohance Lifesciences Q1 Net Loss ₹430M on Revenue Decline
Cohance Lifesciences reported Q1 FY27 consolidated revenue decline of 23.1% YoY to ₹4,223 million with net loss of ₹430 million.
Board approved unaudited financial results for June 2026 quarter and re
